Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 09:17 (847 d 12:25 ago) – Posting: # 20128
Views: 2,401

» » Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)
»
» What does your protocol say on exactly that matter?

My protocol says within (-0.20 and 0.20)

Complete thread:

Activity
 Admin contact
21,594 posts in 4,515 threads, 1,532 registered users;
online 9 (0 registered, 9 guests [including 5 identified bots]).
Forum time: Friday 21:43 CEST (Europe/Vienna)

It is a capital mistake to theorise before one has data.    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5